{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-06",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Kennesaw",
      "state": "GA",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Devices",
      "event_id": "66046",
      "recalling_firm": "Cardiogenesis Corporation",
      "address_1": "1655 Roberts Blvd NW",
      "address_2": "N/A",
      "postal_code": "30144-3632",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "US Distribution",
      "recall_number": "Z-1993-2013",
      "product_description": "Cardiogenesis Corporation - Cardiogenesis Transmyocardial Laser.    The device is indicated for use in the treatment of patients with angina (Canadian Cardiovascular Society Class 4) refractory to medical treatment and secondary to objectively demonstrated coronary artery atherosclerosis and with a region of the myocardium with reversible ischemia not amenable to direct coronary revascularization.",
      "product_quantity": "2498",
      "reason_for_recall": "Following acquisition of Cardiogenesis, we began receiving complaints of sparks, burns, or smoke incidents related to the handpieces.",
      "recall_initiation_date": "20110501",
      "center_classification_date": "20130911",
      "termination_date": "20140915",
      "report_date": "20130918",
      "code_info": "Product Code - HP-SG3  Product Code -HP-PRL5",
      "more_code_info": ""
    }
  ]
}